Page last updated: 2024-11-04

sumatriptan and Cranial Nerve V Diseases

sumatriptan has been researched along with Cranial Nerve V Diseases in 2 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Research Excerpts

ExcerptRelevanceReference
"Levetiracetam is an antiepileptic drug with analgesic efficacy shown in pain models and small clinical trials."1.42The effects of levetiracetam, sumatriptan, and caffeine in a rat model of trigeminal pain: interactions in 2-component combinations. ( Micov, AM; Pecikoza, UB; Popović, BV; Stepanović-Petrović, RM; Tomić, MA, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tomić, MA1
Pecikoza, UB1
Micov, AM1
Popović, BV1
Stepanović-Petrović, RM1
Kayser, V1
Aubel, B1
Hamon, M1
Bourgoin, S1

Other Studies

2 other studies available for sumatriptan and Cranial Nerve V Diseases

ArticleYear
The effects of levetiracetam, sumatriptan, and caffeine in a rat model of trigeminal pain: interactions in 2-component combinations.
    Anesthesia and analgesia, 2015, Volume: 120, Issue:6

    Topics: Analgesics; Animals; Behavior, Animal; Caffeine; Disease Models, Animal; Dose-Response Relationship,

2015
The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
    British journal of pharmacology, 2002, Volume: 137, Issue:8

    Topics: Animals; Dihydroergotamine; Disease Models, Animal; Male; Migraine Disorders; Oxazolidinones; Pain;

2002